What Are Neuroendocrine Tumors (NETs) and How Do Families Plan for End of Life?

The short answer: Neuroendocrine tumors (NETs) are a diverse group of cancers arising from neuroendocrine cells throughout the body — most commonly in the GI tract, pancreas, and lungs. Well-differentiated NETs can be slow-growing, allowing years of planning; poorly differentiated NETs progress rapidly and require urgent end-of-life preparation.

Understanding Neuroendocrine Tumors

NETs encompass a spectrum from indolent, well-differentiated tumors (Grade 1–2) to aggressive, poorly differentiated neuroendocrine carcinomas (Grade 3). GI and pancreatic NETs are often discovered incidentally; lung carcinoids may be found on chest imaging. Carcinoid syndrome — flushing, diarrhea, wheezing from serotonin secretion — occurs in some patients.

Prognosis by Grade and Stage

Well-differentiated, resected small bowel NETs can have 5-year survival rates exceeding 90%. However, metastatic Grade 3 neuroendocrine carcinomas have median survivals of 4–12 months. The wide prognostic range means end-of-life planning timelines vary enormously.

Treatment Landscape

Somatostatin analogues (octreotide, lanreotide) control carcinoid symptoms and slow tumor growth. PRRT (177Lu-DOTATATE, Lutathera) is approved for SSTR-positive NETs. Everolimus and sunitinib are approved for pancreatic NETs. Clinical trials are ongoing.

When to Begin Palliative Care and End-of-Life Planning

For well-differentiated NETs, palliative care integration can begin years before end of life — alongside active treatment. For high-grade NETs, urgent advance care planning is needed at diagnosis. Death doulas help families at both ends of this spectrum.

Frequently Asked Questions

Are neuroendocrine tumors curable?

Some small, localized NETs are curable with surgery. Metastatic well-differentiated NETs may be managed for years with good quality of life. High-grade neuroendocrine carcinomas are generally not curable.

What is carcinoid syndrome?

Carcinoid syndrome occurs when carcinoid tumors (usually with liver metastases) secrete serotonin and other hormones, causing flushing, diarrhea, and wheezing. Somatostatin analogues control these symptoms.

Can a death doula help with NET end-of-life planning?

Yes — whether you have years or months ahead, a death doula can help with advance care planning, legacy work, and family communication across the variable NET timeline.

Where are NET specialists located?

Specialized NET programs exist at MD Anderson, Moffitt, Ohio State, UCLA, and other NCI-designated cancer centers. The Carcinoid Cancer Foundation (carcinoid.org) and NETRF are patient advocacy resources.

Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.